TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- EmergConnect’s digital platform helps hospitals cut ER triage time by up to 60%.

The Trader’s Mind bridges the gap between strategy and success, offering tools like trading journals, breathing techniques, ...

Under the terms of the agreement, DentPrime will serve as an official sponsor of Orli Znojmo throughout the 2025 season, ...

Elite Clinical Network (ECN), a fully-integrated clinical research site network, has appointed Christopher (“Chris”) Brennan ...

Agenda and keynote details now available for the premier annual event advancing health data sharing, health improvement, and ...

Nxera previously announced the initiation of the Phase 3 registrational program of NBI-’568 by Neurocrine in May 2025. The Phase 3 study is a global double-blind, placebo-controlled trial evaluating ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest clinical data from its ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest data from a Phase ...

(2) Carlingview Manor is in the process of being redeveloped into a new 320-bed LTC home that is owned by the joint venture between Extendicare and Axium.

The results of the vote on the election of the Board are as follows: ...

TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, ...

The RSUs are subject to the terms and conditions of LENSAR’s 2024 Employment Inducement Incentive Award Plan and a restricted stock unit agreement covering the grant. LENSAR is a commercial-stage ...